Copyright
©The Author(s) 2021.
World J Hepatol. Jun 27, 2021; 13(6): 686-698
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.686
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.686
Study time period | 1998-2017 | Individual effect (Type III test, P value) | ||
Mortality | Length of stay | Total charges | ||
BCS patients' characteristics | ||||
Age | 50.50 (0.19) | < 0.001 | 0.052 | < 0.001 |
Female | 55.19 (0.54) | 0.003 | 0.001 | < 0.001 |
Race | 0.138 | 0.013 | < 0.001 | |
1: White | 56.03 (0.54) | |||
2: Black | 13.26 (0.37) | |||
3: Hispanic | 9.56 (0.32) | |||
4: Asian/Pacific Islander | 2.56 (0.17) | |||
6: Other | 3.65 (0.2) | |||
9: Unknown | 14.93 (0.39) | |||
Primary payer | < 0.001 | 0.002 | < 0.001 | |
1: Medicare | 33.17 (0.52) | |||
2: Medicaid | 18.42 (0.42) | |||
3: Private insurance | 40.20 (0.54) | |||
6: Other | 8.21 (0.3) | |||
Hospital characteristics | ||||
Hospital size | 0.014 | < 0.001 | < 0.001 | |
1: Small | 9.81 (0.32) | |||
2: Medium | 18.92 (0.43) | |||
3: Large | 71.27 (0.49) | |||
Hospital location and teaching status | 0.195 | < 0.001 | < 0.001 | |
1: Rural | 6.89 (0.28) | |||
2: Urban nonteaching | 24.24 (0.47) | |||
3: Urban teaching | 68.87 (0.51) | |||
Hospital region | 0.533 | 0.010 | < 0.001 | |
1: Northeast | 21.84 (0.45) | |||
2: Midwest | 22.15 (0.46) | |||
3: South | 33.45 (0.52) | |||
4: West | 22.57 (0.46) | |||
Clinical characteristics | ||||
Ascites | 29.93 (0.5) | < 0.001 | < 0.001 | < 0.001 |
Acute kidney injury | 18.84 (0.43) | < 0.001 | < 0.001 | < 0.001 |
Hepatic cirrhosis with no mention of alcohol | 18.65 (0.43) | 0.901 | 0.031 | 0.838 |
Cancer | 17.26 (0.41) | < 0.001 | 0.002 | 0.010 |
Portal hypertension | 16.57 (0.41) | 0.029 | 0.898 | 0.000 |
Hepatic encephalopathy | 9.59 (0.32) | < 0.001 | < 0.001 | < 0.001 |
Portal vein thrombosis | 7.92 (0.3) | 0.006 | 0.372 | 0.073 |
Esophageal varices without bleeding | 7.44 (0.29) | 0.002 | 0.324 | 0.091 |
Acute respiratory Failure | 7.03 (0.28) | < 0.001 | < 0.001 | < 0.001 |
HCC | 6.93 (0.28) | < 0.001 | < 0.001 | 0.543 |
Acute blood loss anemia/hemorrhagic | 6.62 (0.27) | 0.008 | < 0.001 | < 0.001 |
IVC thrombosis | 6.39 (0.27) | < 0.001 | < 0.001 | < 0.001 |
Sepsis | 6.10 (0.26) | < 0.001 | < 0.001 | < 0.001 |
Alcoholic cirrhosis | 5.73 (0.25) | 0.113 | 0.731 | 0.140 |
Acute liver failure | 5.60 (0.25) | < 0.001 | < 0.001 | < 0.001 |
Hepatorenal syndrome | 3.29 (0.2) | < 0.001 | < 0.001 | < 0.001 |
Variceal bleeding | 3.20 (0.19) | 0.107 | 0.160 | 0.001 |
Spontaneous bacterial peritonitis | 2.83 (0.18) | < 0.001 | < 0.001 | < 0.001 |
Intestinal infarct/acute vascular insufficiency | 2.11 (0.16) | < 0.001 | < 0.001 | < 0.001 |
Elixhauser Comoridity Score excluding liver disease | 9.38 (0.12) | < 0.001 | < 0.001 | < 0.001 |
- Citation: Alukal JJ, Zhang T, Thuluvath PJ. Mortality and health care burden of Budd Chiari syndrome in the United States: A nationwide analysis (1998-2017). World J Hepatol 2021; 13(6): 686-698
- URL: https://www.wjgnet.com/1948-5182/full/v13/i6/686.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i6.686